Seminars in Nuclear Medicine

Papers
(The TQCC of Seminars in Nuclear Medicine is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Theranostics in Lung Neuroendocrine Tumors192
Letter from the Editors141
Neurological Disorders and Women's Health: Contribution of Molecular Neuroimaging Techniques91
Non-FDG hypoxia tracers83
Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update76
FAPI-PET in Cardiovascular Disease72
New Promising Targets for Imaging in Cardiovascular Diseases71
New targets of PET imaging for renal cancer63
PET/CT in the Imaging of CNS Tumors56
The Value of FDG PET/CT in Penile Cancer: An Update55
Sentinel Lymph Node Methods in Breast Cancer54
Highlighting New Research Trends on Zirconium-89 Radiopharmaceuticals Beyond Antibodies50
Imaging of Invasive Fungal Infections- The Role of PET/CT47
Autoimmune Thyroid Diseases47
Prognostic Value of PSMA PET/CT in Prostate Cancer45
Pediatric Nephro-Urology: Overview and Updates in Diuretic Renal Scans and Renal Cortical Scintigraphy43
Letter from the Editors42
The Role of Nuclear Medicine in Benign Thyroid Disease42
Molecular Imaging in Inflammatory Bowel Disease41
CD70-Targeted Radiotheranostics: Now and Future41
Controversies in the Radioiodine Treatment of Patients With Differentiated Thyroid Cancer41
Selective Internal Radiotherapy in Liver Tumors: Early Promise Yet to be Fulfilled41
Artificial Intelligence for Drug Discovery: An Update and Future Prospects40
Imaging for Radiation Planning in Breast Cancer39
Imaging trends in diabetic foot infections38
The evolving role of nuclear medicine in osteomyelitis: A narrative review of current evidence and future horizons37
Radionuclide Imaging of Cardiac Amyloidosis: An Update and Future Aspects34
Emerging Trends in Radionuclide Imaging of Infection and Inflammation in Pediatrics: Focus on FDG PET/CT and Immune Reactivity34
The Evolution of Artificial Intelligence in Nuclear Medicine33
PET-CT radiomics for immunotherapy response32
Total-Body PET/CT: A Role of Artificial Intelligence?32
Global experience in brain amyloid imaging31
Current and Future Perspective of PET/CT in Response Assessment of Malignant Pleural Mesothelioma31
New Approaches for Imaging Bacteria29
PET/MR Technology: Advancement and Challenges29
Artificial intelligence for tumor [18F]FDG-PET imaging: Advancement and future trends—part I29
The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) in the Diagnosis and Evaluation of Spondylodiscitis28
Imaging of Cardiac Sarcoidosis: An Update and Future Aspects28
The value of PSMA PET for risk stratification in prostate cancer: an update and future aspects28
18F-Fluoride PET/CT—Updates27
Expanding Role for Gallium-68 PET Imaging in Oncology27
Total-body PET/CT – First Clinical Experiences and Future Perspectives26
Use of Radionuclide-Based Imaging Methods in Breast Cancer26
Renography: Methods and Pitfalls26
Letter From the Editors25
Update on Pediatric Nuclear Medicine in Acute Care25
Total Body Positron Emission Tomography/Computed Tomography: Current Status in Oncology25
The Clinical Impact of FAPI PET Imaging: HCC, CCC, CUP & Peritoneal Carcinoma24
Standardized PSMA-PET Imaging of Advanced Prostate Cancer23
Future Imaging of Prostate Cancer: Do We Need More Than PSMA PET/CT?23
Scintigraphic Diagnosis of Acute Pulmonary Embolism: From Basics to Best Practices23
Fibroblast Activation Protein Inhibitor (FAPI) PET Imaging in Sarcomas: A New Frontier in Nuclear Medicine23
Recent Advances and Future Trends of[18F]-Labeled PET Agents for Renal Imaging22
Radiolabeled Somatostatin Analogs for Cancer Imaging22
Practical approach to diuretic renography in children: Techniques, interpretation, and pitfalls22
18F-Sodium Fluoride PET/CT in Assessing Valvular Heart and Atherosclerotic Diseases22
Therapy strategies to defeat prostate cancer heterogeneity21
Nuclear Medicine Preclinical Research: The Role of Cell Cultures21
Practice of 18F-FDG-PET/CT in ICU Patients: A Systematic Review21
FAPI PET Versus FDG PET/CT in Gastrointestinal Cancers: An Overview21
The Clinical Utility of Molecular Imaging in COVID-19: An Update20
Letter from the Editors20
Advances in PET Imaging of Large Vessel Vasculitis: An Update and Future Trends20
FDG PET/CT for Staging Lung Carcinoma: An Update20
Optimizing CT Imaging Parameters: Implications for Diagnostic Accuracy in Nuclear Medicine20
Artificial Intelligence Augmented Cerebral Nuclear Imaging20
Functional Imaging of Testicular Torsion20
Targeted Radiopharmaceutical Therapy for Bone Metastases20
Nonmalignant findings on FAPI PET: An updated rapid systematic review of the literature20
Development of PSMA-Targeted Alpha Therapy Using [211At]PSMA-519
The role of nuclear medicine in abdominopelvic infections19
Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma19
Academic integrity and artificial intelligence: is ChatGPT hype, hero or heresy?19
Molecular Imaging for Response Assessment of Neuroendocrine Tumors (NET)18
Sentinel Node Mapping in Penile Cancer: An Update on Methods and Pitfalls18
Total-Body PET/CT Metabolic Response in Esophageal Squamous Cell Carcinoma18
A Role of Non-FDG Tracers in Lung Cancer?18
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F]F-FDG Tracers Part II. [F]F-FLT, [F]F-FET, [C]C-MET and Other Less-Commonly Used Radiotrace18
Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PET18
Artificial Intelligence and Workforce Diversity in Nuclear Medicine18
Prostate Cancer Theranostics With 177Lu-PSMA17
Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides17
RETRACTED: Radiotracing the Future: Non-FDG Radiotracers Nuclear Medicine17
Radiomics and Artificial Intelligence Landscape for [18F]FDG PET/CT in Multiple Myeloma17
Hybrid Imaging: Calcium Score and Myocardial Perfusion Imaging16
Neuroimaging of Mild Traumatic Injury16
Letter From the Editors16
Radiolabeled Antibody–Drug Conjugates in the Treatment of Solid Tumors16
Response Evaluation Criteria in Grade 1/2 Neuroendocrine Tumors (RECIN)16
Letter From the Guest Editors16
Advances and challenges of PET imaging in bladder cancer–An update and future trends16
0.1877121925354